Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arterra Bioscience SpA ( (IT:ARBS) ) just unveiled an update.
Arterra Bioscience S.p.A., the Naples-based green biotech listed on Euronext Growth Milan, develops bio-sustainable enabling technologies for sectors including cosmetics, agriculture and nutraceuticals. The company leverages extensive collaborations with firms such as Intercos and Isagro, as well as universities and research institutes, to commercialize innovative skincare and functional make-up solutions.
The company has been approved as a partner in the three-year “Re-Food” project led by the National Research Center for Agricultural Technologies, securing recognition of eligible costs of about €720,000 and a non-repayable grant of roughly €462,000. The initiative reinforces Arterra’s strategic focus on sustainable, innovative biotechnological solutions and is expected to support regional innovation, employment and competitiveness in strategic supply chains.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is an Italian green biotech company focused on research and development in biotechnology, listed since 2019 on Euronext Growth Milan. Based in Naples and founded in 2004, it develops enabling technologies using bacteria, yeasts, and plant and animal cells for applications in cosmetics, agriculture and nutraceuticals, supported by longstanding collaborations and joint ventures with industrial and academic partners.
Average Trading Volume: 19,716
Technical Sentiment Signal: Buy
Current Market Cap: €20.24M
Learn more about ARBS stock on TipRanks’ Stock Analysis page.